Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist
This study has been completed.
Study NCT00303394   Information provided by University of Zurich
First Received: March 14, 2006   Last Updated: March 2, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
IL-1Ra
Additional drug interventions recognized in this trial
Interleukin 1 Receptor Antagonist Protein
More general drug interventions related to this trial
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Zurich
Steno Diabetes Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services